1/2상모집 중
A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple Myeloma
연구 개요
CO43923 is a platform study that will evaluate the safety, efficacy, and pharmacokinetics (PK) of multiple treatment combinations, as monotherapy or in combination, in participants with multiple myeloma (MM). The study is designed with the flexibility to open new treatment substudies as new treatments become available. Information regarding the opened substudies are found below.
- 스폰서
- 리드: 로슈
- 적응증
- Multiple Myeloma
- 중재
- Cevostamab, Lenalidomide, Tocilizumab, Iberdomide, Dexamethasone
- 목표 등록
- 200명
- 시작일
- 2023-11-14
- 완료(예정)
- 2028-07-31
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.